secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001493152-24-051047
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud

NanoVibronix stockholders approve 2024 Long-Term Incentive Plan and elect eight directors at annual meeting.
--------------------------------------------------------------------------------

- Stockholders approved 2024 Long-Term Incentive Plan with 635,057 for, 262,753 against, 2,012 abstentions, and 1,146,998 broker non-votes.
- Eight directors elected: Aurora Cassirer, Christopher Fashek, Michael Ferguson, Martin Goldstein, Harold Jacob, Thomas Mika, Brian Murphy, Maria Schroeder, each receiving 668,461–685,652 for votes.
- Ratification of Zwik CPA as auditor for FY2024 passed with 2,006,926 for, 25,623 against, 14,271 abstentions.
- Advisory vote on executive compensation approved: 629,513 for, 265,874 against, 4,435 abstentions, 1,146,998 broker non-votes.
- Adjournment proposal approved (1,656,819 for, 376,540 against) but not needed as meeting proceeded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224051047/0001493152-24-051047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224051047/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-051047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer